Weisman M, Durm G, Shields MD, Hanna NH, et al. Evaluation of Radiation Pneumonitis in a Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer (NSCLC): Big Ten Int J Radiat Oncol Biol Phys 2024 Oct 25:S0360-3016(24)03450.
PMID: 39490906